Tag: Alkermes Plc

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Alkermes Plc

Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Hold" from Analysts

Added to Collection on: 2021-03-26 09:28:57

Tags for this article:

Chemical compounds

Opioid antagonists

Finance

Click the tags to see associated articles and topics

View Article Details

Craig C. Hopkinson Sells 28920 Shares of Alkermes plc (NASDAQ:ALKS) Stock

Added to Collection on: 2021-04-17 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the ...

Added to Collection on: 2021-04-20 20:07:00

Tags for this article:

Receptor antagonists

Drugs

Serotonin antagonists

Atypical antipsychotics

Mood stabilizers

Dopamine antagonists

Muscarinic antagonists

Olanzapine/samidorphan

Aripiprazole lauroxil

Alkermes Plc

Click the tags to see associated articles and topics

View Article Details

Stock Traders Purchase High Volume of Alkermes Put Options (NASDAQ:ALKS)

Added to Collection on: 2021-04-27 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Is Alkermes Plc (ALKS) Stock at the Top of the Biotechnology Industry?

Added to Collection on: 2021-05-07 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Krensavage Asset Management LLC Has $25.38 Million Stake in Alkermes plc (NASDAQ:ALKS)

Added to Collection on: 2024-03-06 18:28:42

Tags for this article:

Initial public offering

Share price

Share repurchase

Equity

Krensavage Asset Management Llc

Alkermes Plc

Click the tags to see associated articles and topics

View Article Details

Alkermes Reports First Profitable Quarter, Advances Narcolepsy Drug Studies

Added to Collection on: 2024-05-03 20:11:26

Tags for this article:

Sleep disorders

Orexin receptor agonists

Alkermes

G protein-coupled receptors

Orexin

ALKS

Narcolepsy

Idiopathic hypersomnia

Hypocretin (orexin) receptor 2

Buprenorphine/samidorphan

Click the tags to see associated articles and topics

View Article Details

A new class of sleep drugs draws Wall Street's attention | BioPharma Dive

Added to Collection on: 2025-09-09 19:32:56

Tags for this article:

Sleep disorders

Wakefulness-promoting agents

Orexin receptor agonists

Click the tags to see associated articles and topics

View Article Details

Alkermes Names Joshua Reed Chief Financial Officer - Contract Pharma

Added to Collection on: 2025-09-12 17:35:46

Tags for this article:

Alkermes Plc

Alkermes

Chief financial officer

Bristol-Myers Squibb

Joshua Reed

Richard Pops

Click the tags to see associated articles and topics

View Article Details

Alkermes' Strategic CFO Appointment and Its Implications for Narcolepsy Pipeline Advancement

Added to Collection on: 2025-09-14 11:28:10

Tags for this article:

Orexin receptor agonists

Sleep disorders

Molecular neuroscience

Idiopathic hypersomnia

Cataplexy

Joshua Reed

Click the tags to see associated articles and topics

View Article Details

Tag: Alkermes Plc

Recent Related Articles to Alkermes Plc

Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Hold" from Analysts

Craig C. Hopkinson Sells 28920 Shares of Alkermes plc (NASDAQ:ALKS) Stock

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the ...

Stock Traders Purchase High Volume of Alkermes Put Options (NASDAQ:ALKS)

Is Alkermes Plc (ALKS) Stock at the Top of the Biotechnology Industry?

Krensavage Asset Management LLC Has $25.38 Million Stake in Alkermes plc (NASDAQ:ALKS)

Alkermes Reports First Profitable Quarter, Advances Narcolepsy Drug Studies

A new class of sleep drugs draws Wall Street's attention | BioPharma Dive

Alkermes Names Joshua Reed Chief Financial Officer - Contract Pharma

Alkermes' Strategic CFO Appointment and Its Implications for Narcolepsy Pipeline Advancement

Create dashboard for Tag: Alkermes Plc